Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc (APUS) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Apimeds Pharmaceuticals US, Inc (AMEX:APUS).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerAPUS Technical Analysis Summary
Apimeds Pharmaceuticals US, Inc stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Technical conditions suggest Apimeds Pharmaceuticals US, Inc is consolidating, awaiting a decisive move.
RSI (14): 44.91
Stochastic %K: 42.01
Williams %R: -57.78
Rate of Change (ROC): -24.88
Takeaway:Apimeds Pharmaceuticals US, Inc shows neutral momentum, with indicators pointing to indecision.
MACD: -0.13
ADX: 28.87
ATR (14): 0.27
CCI (14): -37.74
Takeaway:Apimeds Pharmaceuticals US, Inc shows weakening trend signals, with bearish pressure building.
Takeaway:Apimeds Pharmaceuticals US, Inc trades closer to support, showing weaker momentum within bands.
Takeaway:Apimeds Pharmaceuticals US, Inc trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:APUS shows balanced money flow with a slight bearish tilt.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Apimeds Pharmaceuticals US, Inc shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.